首页> 外文会议>World biomaterials congress >Injectable hydrogel consisting of bisphosphonate-functionalized hyaluronan and doxorubicin@magnesium silicate nanoparticles for anti-cancer therapy
【24h】

Injectable hydrogel consisting of bisphosphonate-functionalized hyaluronan and doxorubicin@magnesium silicate nanoparticles for anti-cancer therapy

机译:由双膦酸酯官能化透明质酸和多柔比星组成的可注射水凝胶用于杀癌治疗的硅酸镁纳米粒子

获取原文

摘要

Introduction: Hydrogels are promising drug delivery system (DDS) for localized anti-cancer therapy. Non-invasive administration of drug-loaded hydrogels implies injectability of such hydrogels which can be more reliably achieved with self-healing networks made from reversible bonds. In this study, we report on a novel hydrogel material cross-linked through metal-ligand coordination bonds between magnesium silicate (MgSiO_3) nanoparticles and bisphosphonate-functionalized hyaluronan (HA-BP) biopolymer. Mixing-triggered gel formation, self-healing properties of the material as well as recognition of HA by cancer cells through HA-CD44 receptor binding makes this hydrogel a promising DDS for cancer therapy. Materials and Methods: MgSiO_3 nanoparticles were prepared from silica nanoparticles by hydrothermal treatment of SiO_2 with ammonia in the presence of MgCl_2. The resulting MgSiO_3 nanoparticles were loaded with Doxorubicin (Dox) by incubation in the drug solution at room temperature. The drug-loaded MgSiO_3 nanoparticles (DOX@MgSiO_3) were purified from the free drug by centrifugation at 4000 rpm. Hyaluronan (HA) was functionalized with bisphosphonate groups through thiol-ene photoreaction between thiolated-hyaluronan and acrylated bisphosphonate according to our previous report. Hydrogel was formed by mixing equal volumes of 4% (w/v) HA-BP solution and 12% (w/v) dispersion of DOX@MgSiO_3 nanoparticles in PBS buffer. Hydrogel was incubated with 3 mL of PBS at different pH (5.0,6.5 and 7.4). At determined time points, PBS buffer was collected and refreshed with the fresh one. Fluorescence emission spectrum was recorded (490 nm excitation wavelength) to obtain a release profile of Dox. Solutions with the released Dox were applied to MCF-7 cells to examine cytotoxicity using MTS method. Results and Discussion: MgSiO_3 nanoparticles were 350nm in diameter and had mesoporous structure. We found that BP groups of HA-BP and Mg~(2+) ions on the surface of MgSiO_3 nanoparticles were two key factors to form hydrogel via coordination bonds. DOX release profile was pH-dependent, showing 67% Dox released already after 24 hours of incubation under pH 5.0 and 47% Dox released after 72 hours of incubation at pH 6.5. Almost no release was detected at neutral pH environment This result can be explained by protonation of BP groups and subsequent braking of coordination bonds with Mg~(2+) ions. This leads to the disassembly of the polymer-nanoparticles network. Our observation that no Dox was released under neutral conditions pointed out that the drug could be only released from the nanoparticles after their liberation from the network. Additionally, faster Dox release was observed at more acidic conditions in support to our suggested mechanism of the network formation and disassembly. In vitro cytotoxicity experiments showed 20% viable MCF-7 cells after treatment with the release solutions. Importantly, this level of cytotoxicity was maintained over 3 days for the Dox-loaded hydrogel while the control group of Dox-free hydrogel showed more than 80% viability of MCF-7 cells. Conclusion: We have developed a new DDS based on reversible and pH dependent hydrogel formation between HA-BP and MgSiO_3 nanoparticles which is useful in anti-cancer therapy.
机译:简介:水凝胶是有前途的药物输送系统(DDS)用于局部抗肿瘤治疗。载有药物的水凝胶的非侵入性的给药意味着其可与从可逆键制成自愈网络来更可靠地实现这种水凝胶的可注射性。在这项研究中,我们在一个新颖的水凝胶通过硅酸镁(MgSiO_3)纳米粒子和二膦酸官能化的透明质酸(HA-BP)的生物聚合物之间的金属 - 配位体配位键材料交联的报告。混合引发的凝胶形成,该材料的自愈性能以及通过HA-CD44受体结合的识别HA的癌细胞使得该水凝胶用于癌症治疗的有希望的DDS。材料和方法:MgSiO_3纳米颗粒从二氧化硅纳米粒子通过在MgCl_2存在氨SiO_2的水热处理制备的。将所得MgSiO_3纳米颗粒温育在室温下药物溶液装入多柔比星(DOX)。载药纳米颗粒MgSiO_3(DOX @ MgSiO_3)从通过离心与游离药物以4000rpm进行纯化。透明质酸(HA)与双膦酸盐组通过巯基 - 透明质酸酯和丙烯酸双膦酸盐之间巯基 - 烯光化学反应,根据我们之前的报告功能。水凝胶通过混合的4%相等的体积(W / V)的HA-BP溶液和12%形成(W / V)在PBS中的DOX分散@ MgSiO_3纳米粒子缓冲。水凝胶用3mL的PBS在不同的pH值(5.0,6.5和7.4)中温育。在确定的时间点,PBS缓冲液收集并与新鲜的一个刷新。荧光发射光谱被记录(490纳米的激发波长),以获得的Dox的释放曲线。与释放的阿霉素溶液施加到MCF-7细胞中使用MTS法检测细胞毒性。结果和讨论:MgSiO_3纳米颗粒的直径分别为350nm的和有孔结构。我们发现,HA-BP和Mg〜(2+)MgSiO_3纳米颗粒的表面上的离子的BP组分别通过配位键的两个关键因素以形成水凝胶。 DOX释放曲线是pH依赖性,示出了67%的Dox释放已经在pH 5.0温育24小时和47%的Dox在pH6.5温育72小时后释放之后。几乎没有释放在中性pH环境中检测该结果可通过BP基团的质子化的和用Mg〜(2+)离子的配位键后续制动进行说明。这导致了拆卸聚合物的纳米颗粒的网络。我们的观察,没有在阿霉素中性条件下释放指出,这种药物可以只从纳米粒子从网络上获得解放之后发布。此外,在更酸性的条件下,观察到更快的DOX释放在支持我们建议的网络的形成和拆卸的机构。在体外细胞毒性实验表明与释放溶液处理后20%的活MCF-7细胞。重要的是,这个水平的细胞毒性的保持3天用于装载DOX水凝胶而Dox的游离水凝胶的对照组显示MCF-7细胞的80%以上的存活率。结论:我们已经开发了一种基于HA-BP和MgSiO_3纳米颗粒之间可逆的,并且pH依赖性凝胶形成其在抗癌治疗中有用的新的DDS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号